Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC
Clinical trial NCT06878222 · RECRUITING
Trial details
- NCT number
- NCT06878222
- Sponsor
- Obstetrics & Gynecology Hospital of Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-15
- Primary completion
- 2028-03-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.